홈 > 시장보고서 > 의약품

시장보고서

상품코드

1313694

세계의 구내염 치료 시장-성장, 향후 전망, 경쟁 분석(2023-2031년)

Mouth Ulcers Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

발행일: 2023년 06월 | 리서치사:

Acute Market Reports | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

구내염 치료(Mouth Ulcers Treatment) 시장은 2031년까지 3.5%의 성장이 예상됩니다. 구내염은 구강 점막이나 잇몸 아래에서 발생할 수 있는 고통스러운 궤양으로 씹거나 물거나 먹는 능력을 제한하는 질환입니다. 구내염은 크기, 모양 및 개수에 따라 경미한 궤양(직경 2-8mm), 큰 궤양(더 크고 가장자리가 고르지 않은 궤양), 헤르페스형 궤양(불규칙한 모양의 작은 상처가 여러 개 모여 있는 궤양)으로 분류할 수 있습니다. 구내염의 주요 원인은 바이러스 또는 박테리아 감염, 약물 반응, 충치, 틀니, 기계적 외상, 정서적 스트레스, 영양소 결핍, 호르몬 수치 변화 및 음식 알레르기입니다. 구내염의 유병률은 전 세계적으로 약 4%이며, 아프타성 궤양은 전 세계 인구의 약 25%에 영향을 미치는 가장 흔한 궤양입니다. 구내염 치료 시장은 코르티코 스테로이드, 마취제, 진통제, 항균제 및 항히스타민제와 같은 약물 종류를 기준으로 세분화할 수 있습니다. 구내염 치료 시장은 젤, 스프레이, 구강 청결제 및 로젠지와 같은 제형을 기준으로 세분화 할 수 있으며, 구내염 치료 시장은 적응증에 따라 아프타 구내염, 구강 편평 태선 및 기타로 세분화 할 수 있습니다.

노인 인구 증가, 구내염 유병률 상승, 금연에 대한 국민 건강 의식 증가가 구내염 치료 시장을 견인할 것으로 보입니다. 한편, 신흥 국가에서는 공중 보건에 대한 의식이 낮고 구강 케어 제품의 허브 요법과 같은 대체 제품을 사용할 수 있다는 것이 구내염 치료 시장의 성장을 억제합니다. 또한, 제형에 사용되는 화학물질의 부작용과 유해 반응은 구내염 치료 시장의 성장에 악영향을 미칩니다.

북미 시장은 구강 및 치과 치료 진단 절차의 기술적 진보로 구내염 치료 시장을 독점할 것으로 예측됩니다. 아시아 태평양에서는 건강 의식을 높이고 비용 효과적인 치료 절차를 통해 구내염 치료 시장의 유리한 성장이 기대됩니다.

시장 개요
구내염 치료 시장 : 약제 클래스별(2021-2031년)
구내염 치료 시장 : 배합별(2021-2031년)
구내염 치료 시장 : 적응증별(2021-2031년)
구내염 치료 시장 : 지역별(2021-2031년)
- 영국 및 유럽 연합
  - 영국
  - 독일
  - 스페인
  - 이탈리아
  - 프랑스
  - 기타 유럽

제10장 아시아 태평양의 구내염 치료 시장(2021-2031년)

시장 개요
구내염 치료 시장 : 약제 클래스별(2021-2031년)
구내염 치료 시장 : 배합별(2021-2031년)
구내염 치료 시장 : 적응증별(2021-2031년)
구내염 치료 시장 : 지역별(2021-2031년)
- 아시아 태평양
  - 중국
  - 일본
  - 인도
  - 호주
  - 한국
  - 기타 아시아 태평양

제11장 남미의 구내염 치료 시장(2021-2031년)

시장 개요
구내염 치료 시장 : 약제 클래스별(2021-2031년)
구내염 치료 시장 : 배합별(2021-2031년)
구내염 치료 시장 : 적응증별(2021-2031년)
구내염 치료 시장 : 지역별(2021-2031년)
- 남미
  - 브라질
  - 멕시코
  - 기타 남미

제12장 중동 및 아프리카의 구내염 치료 시장(2021-2031년)

시장 개요
구내염 치료 시장 : 약제 클래스별(2021-2031년)
구내염 치료 시장 : 배합별(2021-2031년)
구내염 치료 시장 : 적응증별(2021-2031년)
구내염 치료 시장 : 지역별(2021-2031년)
- 중동 및 아프리카
  - GCC
  - 아프리카
  - 기타 중동 및 아프리카

제13장 기업 개요

Blistex Inc.
Bristol-Myers Squibb Company
Church & Dwight Co Inc.
Colgate Palmolive Company
Dr. Reddya€(TM)s
GlaxoSmithKline plc
Patterson Dental Supply Inc.
Pfizer Inc.
Prince Care Pharma Private Limited
3M
기타 주요 기업

LYJ 23.08.31

Mouth ulcers treatment market expected to Grow at 3.5% by 2031, mouth ulcers are painful sores that can be developed in mucous membrane of oral cavity or at the underneath of gums and restricts individual's ability to chew, bite or eat. Depending on the size, shape and number the mouth ulcer can be classified as minor ulcer (2-8 mm diameter), major ulcer (bigger and uneven edges) and herpetiform ulcer (bunch of smaller injuries with irregular shapes). The principle causes of mouth ulcer are viral or bacterial infection, drug reaction, tooth decay, dentures, mechanical trauma, emotional stress, nutrients deficiency, changes in hormonal level and food allergy. The prevalence of mouth ulcer is around 4% globally and aphthous ulcer is the most common affecting around 25% population worldwide. The mouth ulcer treatment market can be segmented on the basis of drug class such as corticosteroids, anesthetics, analgesics, antimicrobial and antihistamines. The mouth ulcer treatment market can also be segmented on the basis of formulation such as Gel, Spray, Mouthwash and Lozenges, while the mouth ulcer treatment market can be segmented as Aphthous stomatitis, Oral Lichen Planus and others on the basis of indication.

Increasing geriatric population, rising prevalence of mouth ulcer and growing health awareness among public to quit smoking would drive the mouth ulcer treatment market. The advanced healthcare infrastructure of developed countries along with high market entrance of variety of oral hygiene care products shall further fuel the growth of the mouth ulcer treatment market; whereas the lack of awareness about public health in developing nations and availability of substitute products like herbal remedies of oral care products restrain the growth of mouth ulcer treatment market. Additionally, the side-effects or adverse reactions of the chemicals used in formulations negatively influence the growth of the mouth ulcer treatment market.

North America market is anticipated to dominate the Mouth ulcers treatment market due to the technological advancement in the diagnostic procedures of oral and dental care. Lucrative growth in mouth ulcer treatment market is expected in Asia-Pacific region due to rising health awareness and cost-effective treatment procedures.

Key Players Identified for Mouth Ulcers Treatment Market include:

Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy's, GlaxoSmithKline, plc, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, 3M And Other Notable Players.

This report offers:

An overview of the global markets for Mouth Ulcers Treatment Market.

Market trends assessment for the period 2020-2030, with historical information for 2020, and projections through 2030, with respective CAGRs during 2022-2030.

Qualitative assessment tools such as market drivers, challenges and future prospects.

Market competition scrutiny tools such as market share analysis, fractal map assessment.

Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics.

A general overview of the industry structure.

Company profiles highlighting key information about the major players operating in the Mouth Ulcers Treatments Market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofMouth Ulcers Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Mouth Ulcers Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

Corticosteroids
Anesthetics
Analgesics
Antimicrobial
Antihistamines

Formulation

Gel
Spray
Mouthwash
Lozenges

Indication

Aphthous Ulcer
Oral Lichen Planus
Others

Region Segment (2021-2031; US$ Million)

North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Mouth Ulcers Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Mouth Ulcers Treatment market?

Which is the largest regional market for Mouth Ulcers Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Mouth Ulcers Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Mouth Ulcers Treatment market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Mouth Ulcers Treatment Market
2.2. Global Mouth Ulcers Treatment Market, By Drug Class, 2022 (US$ Million)
2.3. Global Mouth Ulcers Treatment Market, By Formulation, 2022 (US$ Million)
2.4. Global Mouth Ulcers Treatment Market, By Indication, 2022 (US$ Million)
2.5. Global Mouth Ulcers Treatment Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022

3. Mouth Ulcers Treatment Market: Competitive Analysis

3.1. Market Positioning of Key Mouth Ulcers Treatment Market Vendors
3.2. Strategies Adopted by Mouth Ulcers Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Mouth Ulcers Treatment Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Mouth Ulcers Treatment Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Corticosteroids
- 5.3.2. Anesthetics
- 5.3.3. Analgesics
- 5.3.4. Antimicrobial
- 5.3.5. Antihistamines

6. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Gel
- 6.3.2. Spray
- 6.3.3. Mouthwash
- 6.3.4. Lozenges

7. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Aphthous Ulcer
- 7.3.2. Oral Lichen Planus
- 7.3.3. Others

8. North America Mouth Ulcers Treatment Market, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
8.3. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
8.4. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
8.5.Mouth Ulcers Treatment Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 8.5.1.1.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 8.5.1.1.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 8.5.1.2.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 8.5.1.2.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 8.5.1.3.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 8.5.1.3.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

9. UK and European Union Mouth Ulcers Treatment Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
9.3. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
9.4. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
9.5.Mouth Ulcers Treatment Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.1.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.1.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.2.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.2.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.3.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.3.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.4.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.4.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.5.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.5.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 9.5.1.6.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 9.5.1.6.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

10. Asia Pacific Mouth Ulcers Treatment Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
10.3. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
10.4. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
10.5.Mouth Ulcers Treatment Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.1.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.1.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.2.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.2.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.3.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.3.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.4.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.4.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.5.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.5.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 10.5.1.6.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 10.5.1.6.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

11. Latin America Mouth Ulcers Treatment Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
11.3. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
11.4. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
11.5.Mouth Ulcers Treatment Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 11.5.1.1.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 11.5.1.1.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 11.5.1.2.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 11.5.1.2.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 11.5.1.3.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 11.5.1.3.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

12. Middle East and Africa Mouth Ulcers Treatment Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
12.3. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
12.4. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
12.5.Mouth Ulcers Treatment Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 12.5.1.1.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 12.5.1.1.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 12.5.1.2.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 12.5.1.2.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Mouth Ulcers Treatment Market: By Drug Class, 2021-2031, USD (Million)
    - 12.5.1.3.2. Mouth Ulcers Treatment Market: By Formulation, 2021-2031, USD (Million)
    - 12.5.1.3.3. Mouth Ulcers Treatment Market: By Indication, 2021-2031, USD (Million)

13. Company Profile

13.1. Blistex Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Bristol-Myers Squibb Company
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. Church & Dwight Co, Inc.
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. Colgate Palmolive Company
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. Dr. Reddya€™s
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. GlaxoSmithKline, plc
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. Patterson Dental Supply, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Pfizer Inc.
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. Prince Care Pharma Private Limited
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. 3M
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Other Notable Players
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,500

￦ 6,354,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 10명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,500

￦ 9,178,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 9,000

￦ 12,708,000

※ 부가세 별도